Basil Hubbard

Title: Innovations of Basil Hubbard in Genome Manipulation

Introduction

Basil Hubbard is a notable inventor based in Edmonton, Canada. He has made significant contributions to the field of genome manipulation, particularly through his innovative work on engineered transcriptional activator-like effectors (TALEs). With a total of 2 patents, his research has implications for both research and clinical applications.

Latest Patents

Hubbard's latest patents focus on the evolution of TALEs, which are versatile tools for genome manipulation. One of the main drawbacks of TALEs is their specificity for the 5' nucleotide of the target, which is limited to thymine (T). His work provides methods and strategies for the continuous evolution of proteins that comprise DNA-binding domains, such as TALE domains. This includes evolving proteins under positive selection for desired DNA-binding activity and negative selection against undesired off-target activities. His patents also detail engineered TALE domains and TALEs that possess altered 5' nucleotide specificities, enhancing their ability to target a broader range of DNA sequences.

Career Highlights

Basil Hubbard is affiliated with Harvard College, where he continues to advance his research in genome manipulation. His innovative approaches have positioned him as a key figure in the field, contributing to the development of high-fidelity binding applications.

Collaborations

Hubbard has collaborated with notable researchers such as David R. Liu and Ahmed Hussein Badran. These collaborations have further enriched his research and expanded the impact of his innovations in the scientific community.

Conclusion

Basil Hubbard's work in the evolution of TALEs represents a significant advancement in genome manipulation technologies. His contributions are paving the way for more precise and versatile applications in both research and clinical settings.